128 articles - From Friday Feb 13 2026 to Friday Feb 20 2026
Guidelines and related publications, position statements, white papers, technical reviews, consensus statements, etc…
| Clin Gastroenterol Hepatol |
|---|
| AGA Clinical Practice Update on Management of Gastric Polyps: Expert Review.
If the polyp is biopsied or resection is incomplete, follow-up endoscopy is advised within 3 months for high-grade dysplasia and 6 months for low-grade dysplasia. BPA 14: Endoscopic surveillance is advised in patients with gastric polyps when the histopathology of adjacent mucosa confirms GIM and/or atrophic gastritis. |
| Endosc Int Open |
| Adherence to ESGE guidelines on biliary stenting in malignant distal strictures: Results from a prospective Italian registry.
Adherence to ESGE guidelines needs to be improved in specific areas, including excessive use of plastic stents, use of U-SEMS without pathological diagnosis, and routine performance of sphincterotomy and use of antibiotic prophylaxis. (ClinicalTrials.gov ID NCT05761496). |
meta-analyses and systematic reviews
| Aliment Pharmacol Ther |
|---|
| Systematic Review of Published Guidelines: Recommendations for Exams Under Anaesthesia, Seton Insertion and Timing of Seton Removal for Perianal and Rectovaginal Fistulising Crohn's Disease.
Substantial heterogeneity and limitations exist across guidelines on the surgical management of pfCD. This underscores the need for international consensus informed by multidisciplinary expertise to standardise care in this complex population. |
| Am J Gastroenterol |
| A systematic review of efficacy in irritable bowel syndrome: How the number needed to treat may be a misleading metric.
When standardized endpoints are used, the NNTs for included IBS pharmacotherapies are similar across indications. Failure to account for endpoint heterogeneity in clinical trials for IBS may distort comparative effectiveness conclusions, undermining clinical decision-making. |
| Antibiotic Use Linked to Worse Outcomes in Gastrointestinal and Liver Cancer Patients on Immune Checkpoint Inhibitors: A Meta-Analysis.
Antibiotic use is associated with worse outcomes in gastrointestinal or liver cancer patients receiving ICIs and should be carefully justified. Prospective studies are needed to validate these results. |
| Clin Gastroenterol Hepatol |
| Effectiveness and safety of JAK inhibitors in acute severe ulcerative colitis: A systematic review and meta-analysis.
JAK inhibitors are effective and safe in the treatment of ASUC as an adjunct to intravenous corticosteroids and as rescue therapy. Both tofacitinib and upadacitinib were associated with similar outcomes in ASUC. Randomised controlled trials evaluating the role of JAK inhibitors as co-therapy with corticosteroids and as a salvage therapy agent in corticosteroid non-responsive ASUC are required. |
| Gastrointest Endosc |
| Management of gastric biopsies indefinite for dysplasia: a systematic review and meta-analysis.
The meta-analysis results showed a considerably high rate of gastric cancer diagnosis among patients with gastric IND, particularly in the intervention group and in the older age subgroup. We recommend that guideline societies recognize gastric IND as an independent lesion and work toward a consensus on the cytopathological features that define it. |
| J Hepatol |
| Global epidemiology of bacterial infections in patients with cirrhosis: a systematic review and meta-analysis.
The increase of Gram-positive and AMR-related infections may inform future empirical antibiotic strategies. Pronounced regional and economic disparities in infection patterns warrants region-specific efforts to mitigate AMR. Persistent challenges remain in reducing long-term mortality. Prospero registration number CRD42024593473. Impact and implications The epidemiology of bacterial infections is critical to guide clinical and public health decision-making, yet comprehensive global data remain limited. This systematic review and meta-analysis offer a detailed global overview of microbiological profiles, antimicrobial resistance patterns, and clinical outcomes associated with bacterial infections in cirrhosis, revealing substantial temporal and geographical variations. The high proportion and growing global burden of antimicrobial resistance among patients with cirrhosis underscore the urgent need for both international collaboration and context-specific national strategies. |
RCT, clinical trials, retrospective studies, etc…
| Aliment Pharmacol Ther |
|---|
| Altered Pathogen Spectrum of Spontaneous Bacterial Peritonitis in Patients Treated With Proton Pump Inhibitors.
PPI treatment is associated with increased abundances of gram-positive pathogens, including Enterococcus spp., in culture-positive SBP. This result can help guide empiric antibiotic therapy of SBP. |
| Long-Term Use of Fenofibrate as Second-Line Therapy in Primary Biliary Cholangitis: A Retrospective Study.
In this long-term cohort of PBC patients with insufficient response to UDCA, fenofibrate significantly improved cholestatic markers and prognostic scores over time. Given this, and its favourable safety profile, fenofibrate should be further considered as an accessible and affordable second-line therapy in PBC. |
| Am J Gastroenterol |
| Autonomic Dysfunction in Gastroduodenal Disorders Evaluated through Multimodal Non-Invasive Physiological Testing.
Autonomic dysfunction independently predicted delayed gastric emptying and revealed a gastroparesis mechanism distinct from gastric myoelectrical impairment. Autonomic dysfunction altered the postprandial gastric motor response and was associated with a greater symptom burden. Multimodal physiological testing including autonomic profiling reveals distinct mechanistic subgroups in patients with chronic gastroduodenal symptoms. |
| Biomarker Use in Barrett's Esophagus Surveillance.
As such, many studies to develop validated biomarkers that either assist in dysplasia assessment or independently serve as predictors of progression risk have been performed. In this review, we will summarize some of these studies, primarily focused on p53, abnormal genomic content, and methylated DNA markers, which have shown promise for their ability to identify patients at increased risk of progressing to more advanced disease. |
| Computer-Aided Colonoscopy Alert Fatigue and Its Effect on Adenoma Detection.
CADe assistance significantly improved ADR during early-day colonoscopies, but this benefit disappeared in later-day procedures. This pattern suggests that alert fatigue may limit endoscopists' responsiveness to CADe prompts as the day progresses. |
| ELECTRONIC HEALTH RECORD CLINICAL DECISION SUPPORT TOOL IMPROVES AMBULATORY REFLUX TESTING PRACTICES.
Use of CDS for reflux testing improves ordering practices and meaningful changes clinical management. |
| Hepatic Encephalopathy is the Key Driver of Symptom Burden in a Longitudinal Cohort of Patients with Advanced Chronic Liver Disease: PAL-LIVER sub-study.
Symptom burden in cirrhosis is generally stable but remain high among certain subgroups, especially those with HE. HE is the strongest and most consistent determinant of physical, psychological, and caregiver burden in cirrhosis. These findings highlight the urgent need for novel, HE-targeted interventions and comprehensive symptom management strategies particularly for women and those with alcohol-related liver disease. |
| High Burden of Constipation among Autistic Youth - A Nationwide Query Powered by PCORnet®.
Approximately 1 in 5 autistic children have constipation and experience high unplanned healthcare utilization. |
| Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
In a large, refractory, real-world CD population, RZB induced rapid and sustained favorable clinical, endoscopic, and radiologic outcomes. Importantly, one-year effectiveness was similar in patients with 2, and ≥3 prior failures, supporting RZB as a valuable option for a refractory population. |
| Nociplastic Pain is Associated with Increased Healthcare Utilization and Lower Quality of Life in Patients with Inflammatory Bowel Disease.
NP is common in IBD and linked to psychosocial comorbidity, higher healthcare use, and reduced QoL. |
| Normalization of Dyssynergic Bear Down Patterns in the Seated Position Predicts Normal Balloon Expulsion Testing on High-Resolution Anorectal Manometry.
Testing in the seated position may more reasonably predict BET success. A seated assessment may enhance diagnostic accuracy in defecation disorders. |
| Outcomes of Artificial Intelligence Enhanced Colonoscopy in a Tertiary Clinical Setting.
Implementing CADe in clinical practice significantly improved ADR, PDR, APC, and PPC. However, the increase in ADR appears inflated by the detection of polyps ≤ 5 mm, whose clinical significance in reducing CRC remains uncertain. |
| Risk Factors for Proximal and Distal Advanced Colorectal Conventional and Serrated Neoplasia in Adults Under Fifty Years of Age.
We identified modifiable risk factors including current smoking and higher BMI in young adults with right and left sided colorectal polyps. Older age, male sex and family history were non-modifiable predictors. These data can help to inform screening and prevention of CRC in young adults. |
| Steatotic Liver Disease Has Surpassed Viral Hepatitis as the Leading Cause of Cirrhosis in the U.S. Veterans Health System.
Substantial epidemiologic shifts in cirrhosis in the US over the last decade, driven by the rising burden SLD, underscore the need for multidisciplinary strategies targeting metabolic risk factors and alcohol use. |
| The bidirectional relationship between cognitive function and active inflammatory bowel disease.
These data provide further impetus to effectively treat IBD in older adults and suggest that delayed recall could be a useful screening tool for older adults with IBD. |
| Clin Gastroenterol Hepatol |
| Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease.
CMRFs-particularly T2DM and elevated BMI-were associated with lower recompensation and survival in patients declined for early LT for ALD, even when controlling for disease severity. These findings highlight the importance of considering CMRFs when weighing the potential for recompensation and need for transplantation in patients considered for early LT for ALD. |
| Incidence and risk of colorectal dysplasia in patients with inflammatory bowel disease: A nationwide cohort study.
Patients with IBD and dysplasia have a significantly increased risk of future dysplasia, particularly among patients with HGD. Personalized surveillance strategies based on risk factors are critical for preventing advanced CRN. |
| Endosc Int Open |
| A novel over-the-scope endoscopic assisting platform for expanding therapeutic capabilities: Preclinical feasibility study (with video).
OTS-EAP preserved endoscope flexibility and torque; rapid valve-switching cleared the field within seconds, stents were deployed precisely under endoscopic view, and dual-instrument coordination simplified defect closure. The platform offers an inexpensive, radiation-sparing "third hand" for emergencies, bleeding, stenting, and suturing, warranting clinical translation. |
| Device-assisted enteroscopy: With increasing requirements, national Irish data support a centralized high-volume model to achieve performance targets.
DAE requirement is increasing. Our study suggests that a high-volume model ensures compliance with international KPIs. These data also suggest that conscious sedation is a viable option for the majority of DAEs without reducing effectiveness, while maintaining comfort. |
| Endoscopic resection in treatment of intramural esophageal cysts: Retrospective analysis of 67 cases.
Endoscopic resection of intramural ECs is safe and effective with fairly good long-term follow-up outcomes. The STER technique has advantages of completely resecting intramural esophageal cysts originating from the deep muscularis propria layer, particularly lesions with extraluminal growth. |
| Feasibility of repeat non-exposed endoscopic full-thickness resection of recurrent or residual colonic adenoma after previous full-thickness resection.
Repeat EFTR for recurrence after a previous EFTR is feasible in most patients and only a few patients require surgical resection. The rate of recurrence might be higher than that after primary EFTR, yet there are no differences in AEs. |
| Neoplasia outcomes following colonoscopy for Lynch syndrome at a dedicated center vs. community centers.
A dedicated center with consistently high colonoscopy performance measures and navigation to augment patient adherence provided superior neoplasia outcomes in Lynch syndrome patients compared with community colonoscopy centers. |
| Phase 1 trial of lavage cytology collected with endoscopic ultrasound-guided fine-needle aspiration for preoperative pancreatic cancer.
This novel EUS-guided lavage cytology method was safe and feasible. A Phase 2 trial is planned. |
| Rates of colorectal surgery in patients with non-malignant colorectal polyps: Results from a nationwide study.
Compared with colorectal cancer surgeries, NMCRP surgeries were associated with significantly lower risks of wound, infectious, urinary, pulmonary, gastrointestinal, and cardiac AEs. Although the proportion of NMCRP surgeries has declined, ongoing efforts in education and training are needed to further reduce unnecessary surgeries and improve patient outcomes. |
| Resection of large, broad-based pedunculated and semi-pedunculated colorectal polyps using a scissor-type endoscopic submucosal dissection knife.
ST-ESD is safe and effective for resection of large, broad-based pedunculated and semi-pedunculated colorectal polyps. |
| Safety and efficacy of fully-covered self-expandable metal stent placement for refractory stomal stenosis.
FCSEMSs represent a safe and effective minimally invasive alternative for refractory stomal stenosis, with promising short-term outcomes. |
| Utility of a novel sheath designed for mapping biopsy for preoperative malignant hilar biliary obstruction.
MB using ES significantly improved technical success and specimen quality, providing valuable information for preoperative assessment of patients with biliary tract cancer. |
| Endoscopy |
| Feasibility and safety of endoscopic ultrasound-guided gallbladder drainage for Niemeier type II acute perforated cholecystitis: a multicenter retrospective pilot study.
During a median follow-up of 350 days (interquartile range [IQR] 240-448), Kaplan-Meier stent patency remained at 90.9% and the median patency time was 327 days (IQR 203-413). EUS-GBD appeared feasible and safe for high-risk patients with type II APC, achieving high technical and clinical success with a low rate of adverse events. |
| Generative artificial intelligence for patient education material on gastric cancer prevention.
ChatGPT-4o produced patient materials comparable to DiCE, but both require readability optimization; a human-in-the-loop workflow and future tests across prompts and models are warranted. |
| Gastroenterology |
| Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar Carcinoma.
Our findings demonstrate that immune resistance in FLC is mediated by both local T-cell exclusion and exhaustion, with combination CXCR4 and PD-1 blockade acting cooperatively to overcome these independent mechanisms. These results highlight the versatility of the human TSC system to aid in the study of rare cancer types and provide important preclinical evidence for the rational design of combination immunotherapy in FLC, which currently lacks any effective systemic therapy. |
| Quorum sensing molecules are elevated in long-standing ulcerative colitis and are linked to the development of colitis-associated cancer.
The bacterial QSM C6-scAHL is elevated in UC patients with CAC risk factors. C6-scAHL promotes colon tumor development in mice and drives pro-inflammatory and pro-tumorigenic cytokine production in vitro. Our findings highlight a previously unexplored pathogenetic pathway linking the microbiome to CAC development and suggest targets to modify CAC risk. |
| STING ablation in T cells is required for the efficacy of STING agonists in CAR-T cell immunotherapy of pancreatic cancer.
Our findings suggest that STING KO CAR-T cells stand to benefit from STING agonists to improve CAR-T cell therapy for immune-deprived cancers such as pancreatic cancer. |
| Single-Cell Analysis of Chemotherapy-induced Remodeling Reveals CD276-driven Basal-like Chemoresistance in Pancreatic Cancer.
Our work uncovers the plasticity of PDAC tumor cell states and interactions with the TME that are modified during chemotherapy of unresectable advanced PDAC and pinpoints CD276/B7-H3 as a critical regulator and a promising therapeutic target for overcoming chemotherapy resistance. |
| Gut |
| E-cadherin loss in Cd44-positive gastric cells initiates diffuse gastric cancer in a murine model.
Background inactivation. |
| Hepatology |
| Unraveling the Tapestry: Lessons from multiomics and spatial biology in hepatocellular cancer.
Finally, we explore the translational implications where spatial signatures may guide risk stratification, treatment selection, and clinical trial design. By integrating spatial architecture with molecular function, spatial omics is transforming our understanding of liver cancer biology and paving the way for spatially informed precision oncology. |
| J Hepatol |
| Detection of Esophageal Varices and Prediction of Hepatic Decompensation in Unresectable Hepatocellular Carcinoma using AI: AI Detection of Varices and Decompensation.
HepatoSageCT scores, supplemented with clinical data, enables accurate non-invasive detection of EV in AtezoBev-treated unresectable HCC and stratifying patients based on hepatic decompensation risk, potentially assisting in reducing unnecessary endoscopies and guiding prognosis. Impact and implications The present study demonstrates that foundation models applied to routine CT imaging, when combined with routinely-collected features such as the presence of portosystemic shunts, can accurately predict the presence of esophageal varices and risk of hepatic and first hepatic decompensation in patients with AtezoBev-treated unresectable HCC. These findings are particularly relevant for hepatologists and oncologists, as they highlight a promising non-invasive tool for timely risk assessment in a time-sensitive patient population. While prospective validation is warranted, this approach could support more personalized management and care of patients with unresectable HCC. |
| Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLD.
Annual changes in CMRFs were associated with clinically relevant changes in LSM, CAP, and liver histology. These findings suggest that treatment of metabolic comorbidities is associated with the trajectory of disease progression in MASLD. Impact and implications Guideline-directed treatment of metabolic dysfunction-associated steatotic liver disease is focused on optimal treatment of cardiometabolic comorbidities, but there is limited evidence on the association between outcomes of this treatment and changes in markers of liver health. The results of this study demonstrate that longitudinal changes in these cardiometabolic parameters, particularly those associated with body weight, blood pressure, and glucose intolerance, are associated with both increases and decreases in liver stiffness measurements that represent clinically-meaningful changes in liver health. These results are broadly relevant to the care of persons with MASLD, as these results can provide meaningful treatment targets for guideline development and treating clinicians, as well as provide feasible goals for impacted persons with MASLD. |
Plenty of the editorials are available as full text through the publisher website using the provided link
| Aliment Pharmacol Ther |
|---|
| Editorial: Steroid-Induced Diabetes in Autoimmune Hepatitis-A Call for Treatment Optimization. |
| Clin Gastroenterol Hepatol |
| Beyond Eosinophils: Redefining the Spectrum of Esophageal Inflammatory Diseases Through an Immune-Centric Paradigm.
An immune-centric approach recognizing distinct inflammatory pathways across EIDs offers opportunities for precision medicine, earlier intervention, and development of variant-specific biomarkers and targeted therapies. This paradigm shift is essential for advancing the field beyond arbitrary cell count thresholds toward mechanistic understanding of esophageal inflammation. |
| Endosc Int Open |
| Barrett's esophagus: How can we miss high-grade dysplasia/cancer? |
| Gastroenterology |
| Centrally Mediated Disorders of Gastrointestinal Pain.
Abdominal migraine is newly recognized in adults with paroxysmal, stereotypical episodes of intense abdominal pain. Narcotic bowel syndrome/opioid-induced gastrointestinal hyperalgesia is characterized by the paradoxical development of, or increases in, abdominal pain associated with continuous or increasing dosages of opioids. |
| The Intestinal microenvironment and Disorders of Gut-Brain Interactions.
Along the way, concepts such as the microbiome-gut-brain axis have emerged to explain symptom generation in DGBI, forming the basis for novel diagnostic approaches and therapeutic interventions. Taken together, recent research findings have renewed interest in luminal and enteric phenomena in DGBI. |
| Gut |
| Basal crypt dysplasia in Barrett's oesophagus: ready for prime time?
This review encompasses key features of CD, the diagnostic pitfalls encountered in clinical practice and the underlying biology driving crypt dysplasia. Future studies focusing on the natural history of CD, its molecular underpinnings and interobserver reproducibility will be pivotal in refining diagnostic criteria and improving patient outcomes in BE. |
| Rise of prediagnostic molecular profiling in inflammatory bowel disease-can we close the door before the horse has bolted?
Increased levels of circulating antibacterial and antiviral antibody responses hint towards disordered host-microbe interactions as potential prime triggers for the transition between health and early disease, although it is possible that these serological responses are an epiphenomenon linked to early mucosal damage and microbial translocation. There is now a timely opportunity to develop these different molecular features into scalable and clinically tractable biomarker panels to detect preclinical disease and enable strategies to proactively intercept IBD before it even develops. |
| J Hepatol |
| Approaching the holy grail in autoimmunity: CD19 CAR T-cell therapy in multiorgan IgG4-related disease. |
| Targeting the tumour's Achilles heel: ATR inhibition to exploit a constitutive vulnerability of hepatoblastoma. |
misc publications eg case reports, tools of the trade, images of the month, etc…
| Am J Gastroenterol |
|---|
| Bloating and breath tests: A pragmatic approach. |
| Extensive Pneumatosis due to Colonic Perforation. |
| Letter to the Editor. |
| Oesophageal band ligation successfully controlled sentinel bleeding from an Aorto-Oesophageal Fistula. |
| Endoscopy |
| A case of endoscopic therapy using electrohydraulic lithotripsy under peroral pancreatoscopy via the minor papilla. |
| A case of endoscopic ultrasound-guided vascular intervention for pancreaticojejunal varices via a gastric approach. |
| A case of successful cannulation for biliary enteric anastomosis stenosis via peroral cholangiopancreatoscope. |
| AXIOS stents: not a solution to every problem - or the problems will keep surfacing. |
| Choledochoduodenostomy rescue with cholangioscopic retrieval of a maldeployed fully covered self-expandable metal stent. |
| Clip-assisted distal traction enables efficient en bloc snare excision of a small rectal neuroendocrine tumor. |
| Conservative management of gastric ulcer penetration using a polyglycolic acid sheet: a case report. |
| Diagnostic endoscopic ultrasound-guided fine-needle aspiration for disseminated parasitic leiomyomatosis after hysterectomy. |
| Electrohydraulic lithotripsy-assisted endoscopic retrograde appendicitis therapy for a giant appendiceal fecalith. |
| Endoscopic resection of a gastrointestinal stromal tumor using a new mucosal dissection knife in combination with far-view endoscopic submucosal dissection. |
| Endoscopic ultrasound-guided gallbladder drainage in situs inversus totalis using a loop formation technique. |
| Endoscopic ultrasound-guided hepaticogastrostomy using a novel double-lumen cannula designed for a 0.018-inch guidewire. |
| Endoscopic ultrasound-guided recanalization of pancreaticojejunostomy anastomotic stricture using a forward-viewing echoendoscope. |
| Failure of release of the Hot AXIOS distal flange: "handle springing" as a rescue technique. |
| Full aspiration technique using a 7-Fr double-pigtail stent for endoscopic ultrasound-guided pancreatic fluid drainage of a pancreatic pseudocyst. |
| Handmade snare technique for grasping and repositioning biliary stents via the endoscopic ultrasound-guided hepaticojejunostomy route. |
| Hybrid-argon plasma coagulation for superficial esophageal cancer at risk of airway obstruction: a case report. |
| Laparoscopy-assisted endoscopic ultrasound-guided gastroenterostomy for the treatment of gastric outlet obstruction. |
| Novel endoscopic approach for duodenal neuroendocrine tumors: partial-closure-assisted endoscopic submucosal resection with a ligation device. |
| Novel one-step deployment of Y-shaped metal stent: no more stent-in-stent or side-by-side. |
| Percutaneous endoscopic gastrostomy-assisted placement of endoluminal vacuum-assisted closure for esophageal perforation. |
| Removal of an intra-gallbladder migrated lumen apposing metal stent through a secondary endoscopic ultrasound-guided gallbladder drainage. |
| Rescue endoscopic ultrasound-guided hemostasis for massive gastric cancer bleeding after transcatheter arterial embolization. |
| Rescue multihole metal stent placement to prevent stent migration after endoscopic ultrasound-guided hepaticogastrostomy. |
| Robot-assisted endoscopic closure of a antral defect using a single-arm transluminal endoscopic robot. |
| Spontaneous isolated celiac artery dissection: a rare mimicker of pancreatic mass masquerading as neoplasm. |
| Stent-in-stent placement of multi-hole metal stents (M2) following creation of a gateway by endoscopic ultrasound-guided antegrade stenting after failed balloon assisted endoscopy. |
| Troubleshooting: intraperitoneal migration of a dedicated plastic stent during endoscopic ultrasound-guided hepaticogastrostomy. |
| Underwater endoscopic submucosal dissection with pocket method and an additional working channel: from traction to closure. |
| Usefulness of electrohydraulic lithotripsy gel-immersion cholangioscopy for giant common bile duct stones. |
| Value of contrast-enhanced endoscopic ultrasound and elastography in the diagnosis and evaluation of portal vein thrombus. |
| Gastroenterology |
| BIOFEEDBACK GUIDED BY THORACOABDOMINAL WALL MOTION FOR THE TREATMENT OF RUMINATION: A RANDOMIZED PLACEBO-CONTROLLED TRIAL. |
| Genomic Dissection of Pediatric Protein-Losing Enteropathy and Related Disorders: Clinical, Immunologic, and Therapeutic Insights. |
| Hepatology |
| Battle of the NITs: MAF-5 leads the pack. |
| Fellows' Corner. |
| Rethinking liver transplant allocation: Balancing urgency and utility. |
| Stains in primary biliary cholangitis: Untangling promise from bias. |
| The fiber code: AI predicts HCC in MASLD. |
| When the going gets tough, the tough keep scaling HIMALAYA. |
| J Hepatol |
| From the Editor's Desk... |
| One year after the TransMet trial: Transplant oncology at a turning point. |
Letters to the editors and authors’ replies
| Aliment Pharmacol Ther |
|---|
| Editorial: Steroid-Induced Diabetes in Autoimmune Hepatitis-A Call for Treatment Optimisation. Authors' Reply. |
| Letter on "Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)". |
| Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply. |
| Letter on 'Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)'; Authors' reply. |
| Letter: Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis. |
| Letter: Amino Acid Imbalance Is an Independent Factor for Mortality in Patients With Liver Cirrhosis. Authors' reply. |
| Letter: Amino Acid Imbalance and Mortality in Cirrhosis-Interpretation and Methodological Considerations. |
| Letter: Amino Acid Imbalance and Mortality in Cirrhosis-Interpretation and Methodological Considerations. Authors' Reply. |
| Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis-Authors' Reply. |
| Letter: The Unresolved Issue of NSBB Confounding in Statin Research for Cirrhosis. |
| Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection. |
| Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection. Authors' Reply. |
| Clin Gastroenterol Hepatol |
| Definitional coupling between fatty liver indices and cardiometabolic risk factors in MASLD mortality analyses. |
| Early Hepatic Encephalopathy After TIPS and Survival: Methodological and Clinical Considerations. |
| Interpreting Survival Models in Post-TIPS Hepatic Encephalopathy. |
| Response to: Definitional coupling between fatty liver indices and cardiometabolic risk factors in MASLD mortality analysis. |
| Gastroenterology |
| Enhancing Inpatient Mortality Prognostication in Cirrhosis Patients Through Machine Learning Techniques. |
| Machine Learning in Cirrhosis: Moving from Static Admission Risk to Dynamic Decision Support. |
| Response to "The Natural History of Gastroesophageal Varices in Children With Portal Hypertension". |
| Gut |
| Clarifying the decision rules and implementation boundaries for risk-based HCC surveillance in MASLD. |
| Time to colonoscopy after a positive FIT result matters. |
| J Hepatol |
| Adjuvant Immunotherapy for Hepatocellular Carcinoma: Precision Selection of the Optimal Beneficiary Population as the Core Strategy. |
| Biological ageing metrics in steatotic liver disease: a potential tool for risk stratification? |
| Discrepancies in Treatment Eligibility Across International Guidelines for Chronic Hepatitis B. |
| Establish a streamlined molecular profiling workflow for the clinical management of advanced cholangiocarcinoma. |
| Incidence and Risk Stratification of Hepatitis B Reactivation in Patients Receiving Anti-CD38 Monoclonal Antibody Therapy. |
| Landscape of ALF Neuroprotection Without Invasive Monitoring. |
| Letter: Recurrence pattern for HBV-related HCC after liver transplantation in the antiviral era. Authors' reply. |
| Targeting MARCO in CASH: Balancing Antitumor Immunity and Hepatic Homeostasis. |